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http://www.biomedcentral.com/1472-6963/14/465RESEARCH ARTICLE Open AccessObstacles to the uptake of breast, cervical, and
colorectal cancer screenings: what remains to be
achieved by French national programmes?
Jonathan Sicsic* and Carine FrancAbstract
Background: In France, equality in access to screening has been one of the main thrusts of public policies
implemented between 2009 and 2013 (the national cancer plan). Our aim in this study was to analyse the obstacles
to and levers for breast, cervical, and colorectal cancer screening uptake and their trends over time.
Methods: Based on representative data from the French Health Care and Health Insurance Survey (three
independent, cross-sectional surveys: 2006, 2008, and 2010), multivariate logistic regressions were used to model
the association between the nonuse of screening for the three cancers and various independent variables. Then,
interactions with survey year dummies allowed the changes in the determinants of these cancer screenings over
time to be estimated.
Results: Whereas the incentives for screening were strengthened during the period considered, cervical and breast
cancer screenings decreased, and colorectal cancer screenings increased sharply (from 18.2% (95% CI = [17.0-19.4])
in 2006 to 38.9% (95% CI = [37.4-40.5] in 2010. Under-users of the three cancer screenings were primarily unskilled
workers (ORcervix = 1.64 [1.38-1.95]), individuals without complementary health insurance (ORbreast = 2.05 [1.68-2.51]),
or individuals with free complementary health insurance who more rarely use outpatient care. Moreover, individuals
reporting either risky behaviours, namely heavy smokers (ORcolorectal = 1.70) and high-risk drinkers (ORcervix = 1.42) or
very safe behaviours, namely neither smoking nor drinking, underused screenings. Despite the implementation of
national programmes for breast and colorectal cancer screenings, the disparities and inequalities in screening
uptake did not decrease over the study period.
Conclusions: These results demonstrate the need for additional primary prevention efforts targeting the identified
under-users by focusing on, for instance, individuals with a very healthy lifestyle. Health authorities could also
intensify their efforts to promote increased access to screening for the most disadvantaged individuals.
Keywords: Breast cancer screening, Cervical cancer screening, Colorectal cancer screening, InequalitiesBackground
Cancer is one of the leading causes of disease and mor-
tality [1]. Breast and colorectal cancer are among the
most commonly diagnosed cancers worldwide [2]. Stu-
dies published in the mid-1990s have shown that pre-
vention practices and cancer screening both play a key
role in reducing cancer prevalence, morbidity, and mor-
tality [3-5]. A recent report from the French National
Cancer Institute [6] reaffirms this finding and highlights* Correspondence: jonathan.sicsic@inserm.fr
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article, unless otherwise stated.the central role that primary care physicians play in pro-
viding cancer screening. However, recent analyses of the
inequalities in screening uptake in France as well as
other northern countries are in general agreement,
highlighting the persistent role of socioeconomics (e.g.,
income, educational level, private health insurance ac-
cess) and family structure [7-11]. For instance, concern-
ing breast and cervical cancer, poor, unmarried women
with lower levels of education and less access to health
care are less likely to be tested [11,12]. Beck and Gautier
[13] emphasise the positive impact of being older, living
in a couple, having children, and more frequentlytral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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cer screening uptake. Kobayashi et al. highlight health
literacy and Lo et al. highlight dislike of the test as bar-
riers to colorectal cancer screening in England [14] (and
Great Britain [15], respectively).
Policy mechanisms have been implemented based on
these findings, and cancer screening remains one of the
main thrusts of the French 2009–2013 Cancer Plan, with
a stated priority of combating inequalities in access to
and use of screening. There is no national programme
for cervical screening (only experiments are ongoing),
but national screening programmes targeting breast can-
cer and colorectal cancer have been established in France
since 2004 and 2009, respectively. The national screening
programme for breast cancer targets women between 50
and 74 years of age and consists of sending a voucher
through the mail that allows each eligible woman to
benefit from a free screening at a radiological centre
participating in the programme. The national screening
programme for colorectal cancer targets men and women
between 50 and 74 years of age and consists of sending a
faecal occult blood test (FOBT) (accompanied by direc-
tions on how to perform the test) through the mail, for a
free laboratory analysis. In addition to these programs, in-
centives directed towards GPs have been implemented in
France, targeting breast cancer screening since 2009 and
cervical cancer screening since 2012. These incentives
consist of financial bonuses to referral GPs who have
screened 80% of their eligible patients. Yet, the impact of
these schemes has not been evaluated thus far.
Numerous studies have examined the determinants of
cancer screening uptake, but few studies have analysed
how these determinants have changed over time, par-
ticularly in response to the recent implementation of
mass screenings and/or national programmes. The re-
sults of preliminary studies indicate that in France, the
impact of the social gradient seems to have decreased in
2010 (vs. 2005); however, the inequalities in access for
the poorest individuals have persisted [16]. In a different
context, De Maio et al. [17] show that the impact of
income and educational level on cervical cancer scree-
ning use remained stable between 2005 and 2010 in
Argentina, but in the case of breast cancer, the impact
of education has decreased.
In the context of the strengthening of prevention policies
through the implementation of national screening pro-
grams, financial incentives, and a third National Cancer
Plan, one would expect the screening rates for breast and
colorectal cancers to have increased and the inequalities re-
lated to socioeconomics and/or health care access to have
decreased between 2006 and 2010. The objective of this
paper is to model the determinants of the failure to partici-
pate in cervical, breast, and colorectal cancer screenings in
France and to study the trends in these determinants overtime, i.e., between 2006 and 2010. The goal is twofold:
first, to contribute to the debate on the efficacy of policies
implemented to reduce screening disparities and/or in-
equalities and, second, to identify potential remaining ob-
stacles to screening to better target and tailor policies
promoting screening use. Throughout the paper, the term
“inequalities” refers to observed disparities in cancer
screening uptake that are assumed to arise from access to
care or systemic barriers. The term “differences” refers to
the associations between other variables/determinants
(e.g., socioeconomic status, risky behaviours) and cancer
screening uptake, for which determining whether they are
related to the choices of patients or the equity of the
health care system is not possible.
Methods
The ESPS survey
The Health Care and Health Insurance Survey (Enquête
Santé et Protection Sociale, ESPS) was conducted by the
Research and Information Institute for Health Economics
(IRDES) annually between 1988 and 1997 and has been
conducted every 2 years since 1998. The ESPS is admi-
nistered to a representative, population-based sample of
French households that are randomly drawn from public
health insurance files. It combines interviews (telephone
or face to face) and self-administered questionnaires [18].
The declarative data provide information on both the
household (income, household type, region of residence)
and its members (e.g., socioeconomic characteristics,
health care, and prevention behaviours). All of the benefi-
ciaries of health insurance belonging to the ESPS sample,
as well as members of their households, were surveyed
every four years. The sampling database was renewed in
2010; thus, the 2006, 2008 and 2010 ESPS samples com-
prised different subpopulations. The response rates were
63% in 2006, 65% in 2008, and 66% in 2010.
Ethics
This study was planned as a research project. All precau-
tions were taken by the IRDES to ensure anonymity of the
data. The construction of the ESPS samples as well as data
analysis was approved by the CNIL (Commission Nationale
de l’Informatique et des Libertés, French law no. 78–17,
authorisation number: 1147702)a. According to the
French law, written informed consent was not required
for this type of study. The three ESPS databases are avail-
able upon request and research collaboration with the
IRDES.
Dependent variables
We were interested in 3 outcomes: cervical, breast, and
colorectal cancer screenings following the French
Health Authority’s guidelines. The first outcome of
interest was whether a woman between 25 and 65 years
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past 3 years. The second outcome of interest was
whether a woman aged between 50 and 74 years re-
ceived a mammogram for breast cancer in the past
2 years. The third outcome of interest was whether an
individual aged between 50 and 74 years performed a
FOBT for colorectal cancer in the past two years.Independent variables
The determinants of the cancer screening uptake were
grouped into 3 categories: (1) socioeconomic charac-
teristics, (2) health and health care consumption, (3)
risky behaviours and prevention use. For category 1,
we considered age, region of residence, social class
(following the French National Institute of Statistics
and Economic Studies codification), marital status, and
complementary health insurance status (private/free/
no)b. In category 2,a dichotomous variable indicating
whether the individual reported having a chronic dis-
ease (yes/no) was used, and individuals’ opinion of
their health was measured with a 4-category, self-rated
health variable constructed from a 10-point Likert scale
(0 = lowest health state, 10 = best health state). Health
care consumption was measured based on the number
of consultations with a GP over the past 12 months and
the number of consultations with a specialist over the
past 12 months. In category 3, risky behaviours were
measured via the levels of tobacco and alcohol con-
sumption. Four classes were defined to describe risky
behaviours related to tobacco use: nonsmokers, ex-
smokers, light smokers (i.e., smoking 10 or fewer ciga-
rettes per day), and heavy smokers (i.e., smoking more
than 10 cigarettes per day). Similarly, four alcoholism
profiles were constructed following a well-established
typology based on the Alcohol Use Disorders Iden-
tification Test (AUDIT-C) questionnaire [19,20]: non-
drinkers, safe consumers, occasionally risky consumers,
and high-risk consumers. To address prevention use,
we included screening activity for other cancers for
which individuals were eligible. Thus, in the model for
individual breast cancer screening uptake, we included
whether the woman had received a FOBT in the past
2 years as a predictor, and in the model for individual
colorectal cancer screening (females only), we included
whether the woman had received a mammogram in the
past 2 years as a predictorc.Descriptive statistics
The descriptive statistics were used, first, to assess the
levels and trends in cervical, breast and colorectal can-
cer screening uptake and, second, to examine whether
the distributions of the independent variables were simi-
lar across the surveys.Analytical strategy
The three ESPS samples (2006, 2008, and 2010) were
pooled, and a multivariate logistic model was estimated
to determine the association between the failure to ob-
tain a screening for each of the three cancers with the
independent variables, thereby enabling us to highlight
persistent differences in screening behaviours. Because
all three screenings are applicable to women but only
one (colorectal) is applicable to men, separate analyses
were conducted by sexed. Two distinct models were
estimated for breast cancer screening (colorectal cancer
screening): model 1 did not include the FOBT (mammo-
gram) variable as a predictor; whereas model 2 did. Be-
cause the inclusion of these variables was suspected to
introduce bias into the models, we choose to report the
results of model 1. Specific categories of nonresponse
were created for each independent variable and included
in the models, but we do not report their results, as we
were not interested in their effects.
Then, to analyse the changes in the determinants of the
failure to obtain screenings over time, we analysed the in-
teractions between the determinants of interest (e.g., age,
social class, complementary health insurance, risky be-
haviours) and survey year dummies (i.e., 2008 vs. 2006
and 2010 vs. 2006 for the breast cancer and cervical
screening models and 2010 vs. 2008 for the colorectal can-
cer screening model), and in the final model, we included
the interactions that were statistically significant at the 5%
level (selected through backward deletion).
Results
Descriptive statistics
The results regarding the trends in cervical, breast, and
colorectal cancer screenings between 2006 and 2010 are
displayed in Figure 1, Figure 2 and Figure 3.
Whereas 75.3% (95% CI = [74.1%-76.5%]) of women re-
ported having received a test for cervical cancer in 2006,
this rate decreased significantly to 71.9% (95% CI =
[70.5%-73.3%]) in 2010. The screening rate for breast
cancer decreased (but not significantly at the 5% level)
between 2006 and 2010, from 77.6% (95% CI = [75.8%-
79.3%]) in 2006 to 74.0% (95% CI = [72.1%-75.9%]) in
2010. Overall, colorectal cancer screening uptake in-
creased significantly between 2006 and 2010, from 18.2%
(95% CI = [17.0%-19.4%]) in 2006 to 38.9% (95% CI =
[37.4%-40.5%] in 2010. As shown in Figure 3, the increase
was sharper for women, whose screening uptake increased
from 16.9% (vs. 19.6% for males) in 2006 to 40.0%
(vs. 38.0% for males).
Table 1 presents the distribution of the independent
variables according to the survey year. For most deter-
minants of cancer screening uptake, the proportion of
respondents in the various categories did not change
across the surveys. The main exceptions are having free
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Figure 1 Trends in cervical screening uptake between 2006
and 2010.
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Figure 3 Trends in colorectal cancer screening between 2006
and 2010.
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a chronic disease (58.5% in 2010 vs. 68.8% in 2006),
having seen a specialist a least once (47.1% in 2010 vs.
42.0% in 2008) and never drinking alcohol (19.3% in
2008 vs. 24.2% in 2010).
Multivariate analyses
Cervical screening
The results of the main-effects and interactions models
for cervical screening are displayed in Table 2 (only one
interaction was significant at the 5% level).
All of the variables explained the failure to obtain a test
for cervical cancer in the multivariate analyses (N = 13,177
observations used). Compared to younger women (25–34
years), women aged 45–54 years or 55–65 years were
more likely not being screened (OR45–54 = 1.56 [1.37-
1.78], OR55–65 = 2.39 [2.08-2.74]. The negative impact77.6
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Figure 2 Trends in breast cancer screening uptake between
2006 and 2010.of age on cervical screening has increased over time: com-
pared to women aged 25–34 years in 2006, women aged
45–65 years had a higher likelihood of not being screened
in 2010. Compared to women having an intermediate pro-
fession, living in a couple, and having private comple-
mentary health insurance, women who were farmers,
office workers, skilled/unskilled workers, or unemployed;
who were single; who did not have private health insu-
rance; who had free complementary health insurance (the
CMU-C) were significantly more likely to report not being
screened. In addition, women who reported having a
chronic disease, having good, fair, or poor self-rated
health, and using medical care less often (no consultation
with a specialist and fewer than two visits to a GP over
the past 12 months), were more likely to not have received
a screening compared to women who reported greater ac-
cess to medical care, no chronic disease, and very good
self-rated health. Finally, regarding so-called risky life-
styles, the results regarding the probability of not being
screened for cervical cancer followed a U-shaped curve:
compared to not smoking, being an ex-smoker or a light
smoker decreased whereas being a heavy smoker increased
the likelihood of not being screened (ORex-smoker = 0.84
[0.74-0.94], ORlight-smoker = 0.81 [0.70-0.92], ORheavy smoker =
1.36 (1.18-1.56). Similarly, compared to safe drinkers, not
drinking alcohol or being a high-risk drinker increased
the likelihood of not being screened (ORneverdrink = 1.44
[1.30-1.59], ORhighrisk = 1.42 [1.09-1.85]). All else being
equal, the survey year had a significant impact on whether
women reported being screened: women had a higher
probability of not being screened for cervical cancer in
2010 than in 2006 (OR2010 = 1.15 [1.03-1.27].Breast cancer screening
The results of the main-effects model for breast cancer
screening are displayed in Table 3 (no interactions were
significant at the 5% level).
Table 1 Descriptive statistics: the distribution of the independent variables in the three ESPS surveys
2006 2008 2010
Determinants of cancer screening N % N % N %
Socioeconomic characteristics
Age
[25–49] 5876 56.1 5205 53.2 4825 54.0
[50–65] 3404 32.5 3372 34.5 3092 34.6
[66–74] 1203 11.5 1209 12.4 1021 11.4
Housing region
Ile de France (without Paris) 1574 15.0 1350 13.8 1256 14.1
Paris and suburbs 1870 17.8 1895 19.4 1614 18.1
North 741 7.1 709 7.3 657 7.4
Est 958 9.1 851 8.7 795 8.9
West 1500 14.3 1443 14.8 1511 16.9
South West 1277 12.2 1134 11.6 1030 11.6
Centre 1468 14.0 1279 13.1 1143 12.8
Mediterrannée 1095 10.5 1125 11.5 914 10.3
Social class
Farmer 353 3.4 302 3.1 259 2.9
Craftsman 581 5.5 595 6.1 521 5.8
Manager 1359 13.0 1291 13.2 1201 13.4
Associate prof. 2159 20.6 2097 21.4 1666 18.6
Office worker 2904 27.7 2761 28.2 2561 28.7
Skilled worker 1766 16.9 1572 16.1 1491 16.7
Nonskilled worker 1046 10.0 939 9.6 880 9.9
Inactive 301 2.9 215 2.2 316 3.5
Marital status
Living in a couple 8425 80.4 7805 79.8 7142 79.9
Single 1115 10.6 1049 10.7 978 10.9
Nonresponse 943 9.0 932 9.5 818 9.2
Complementary health insurance
Private 9150 87.3 8628 88.2 7721 86.4
Free 682 6.5 674 6.9 868 9.7
No 618 5.9 454 4.6 300 3.4
Health and health care consumption
Chronic disease
Yes 2610 24.9 2561 26.2 3196 35.8
No 7217 68.8 6574 67.2 5227 58.5
Don't know 656 6.3 651 6.7 515 5.8
Self-rated health
[0–4] : poor 365 3.5 403 4.1 386 4.3
[5,6] : fair 1604 15.3 1709 17.5 1362 15.2
[7,8] : good 4870 46.5 4699 48.0 4090 45.8
[9,10] : very good 3225 30.8 2555 26.1 2688 30.1
Nonresponse 419 4.0 420 4.3 412 4.6
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Table 1 Descriptive statistics: the distribution of the independent variables in the three ESPS surveys (Continued)
Nb of consultations with a GP
Two or less 4884 46.6 4539 46.4 4133 46.2
Three or more 4983 47.5 4693 48.0 4208 47.1
Nonresponse 616 5.9 554 5.7 597 6.7
Nb of consultations with a specialist
None 4154 39.6 3690 37.7 3302 36.9
At least one 4578 43.7 4112 42.0 4208 47.1
Nonresponse 1751 16.7 1984 20.3 1428 16.0
Risky behaviours
Tobacco consumption
Non-smoker 3608 34.4 3434 35.1 2992 33.5
Ex-smoker 2825 27.0 2562 26.2 2101 23.5
Light smoker 1357 12.9 1412 14.4 1495 16.7
Heavy smoker 1428 13.6 1241 12.7 1161 13.0
Nonresponse 1265 12.1 1137 11.6 1189 13.3
Alcohol consumption
Non drinker 2234 21.3 1893 19.3 2164 24.2
Safe consumer 4590 43.8 4338 44.3 3676 41.1
Occasionnaly risky consumer 2575 24.6 2288 23.4 1997 22.3
High risk consumer 531 5.1 748 7.6 629 7.0
Nonresponse 553 5.3 519 5.3 472 5.3
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used), women who reported not being screened more
commonly were unskilled worker (OR = 1.62 [1.26-2.09])
or unemployed (OR = 1.61 [1.14-2.28]), single (OR = 1.45
[1.17-1.80]), and did not have a private complementary
health insurance (OR = 2.08 [1.57-2.75]) or received free
complementary health insurance (OR = 1.79 [1.36-2.37]).
In addition, reporting a chronic disease (OR = 1.29 [1.11-
1.59]), self-reporting poor health (OR = 1.87 [1.38-2.54]),
having a low number of consultations with a GP (OR =
1.40 [1.21-1.62]) or a specialist (OR = 3.00 [2.59-3.47],
being a heavy smoker (OR = 1.84 [1.44-2.37]) and never
drinking alcohol (OR = 1.84 [1.44-2.37]) significantly in-
creased the probability of not being screened. All else
being equal, women were more likely to have not been
screened for breast cancer in 2010 than in 2006. We
performed a complementary analysis including FOBT up-
take in the model and found a significant impact of the
variable: all else being equal, not having received FOBT in-
creased the odds ratio associated to not having performed
a mammogram by 3.82 [3.18-4.60].Colorectal cancer screening
The results of the main-effects and interactions models
for colorectal cancer screening are displayed in Table 4(N = 5,927 observations used for males and N = 6,229
observations used for women).
For the two genders, the determinants of not being
screened were being younger (50–54 years of age), being
an unskilled worker, having less health care consumption
(fewer than 3 visits to a GP or no visits to a specialist
over the past twelve months), and being a heavy smoker.
All else being equal, the likelihood of not being screened
for colorectal cancer was significantly lower in 2010 than
in 2008. There were differences regarding the impact of
other determinants on FOBT uptake between males
and females: females reporting poor health (OR = 1.48
[1.07-2.03]) and never drinking alcohol (OR = 1.22 [1.05-
1.42]) had a higher likelihood of not being screened, but
it was not the case for males. Conversely, being a light
smoker increased the likelihood of not being screened
for males (OR = 1.28 [1.03-2.22]) but not for females.
One interaction was significant in the model for males:
compared to having private complementary insurance,
having free complementary health insurance (the CMU-C)
was associated with a reduced probability of not being
screened for colorectal cancer in 2008 (OR = 0.53 [0.30-
0.94]) but a higher probability of not being screened in
2010 (OR = 4.31 [1.90-9.76]). We performed a second ana-
lysis for females in which we included whether they had
received a mammogram in the past two years into the
Table 2 Multivariate logistic regression models of the absence of cervical screening (N = 13,177 women)
Independant variables No cervical screening main effects model No cervical screening interactions model
OR (95 CI) OR (95 CI)
Socioeconomic characteristics
Age (ref = 25–34)
[35–44] 1.05 (0.92-1.20) 1.01 (0.81-1.25)
[45–54] 1.56*** (1.37-1.78) 1.19 (0.97-4.47)
[55–65] 2.39*** (2.08-2.74) 2.05*** (1.65-2.56)
Age *survey year (ref: age = '25-34'; survey year = '2006')
[45–54]*2008 … 1.50*** (1.11-2.03)
[45–54]*2010 … 1.54*** (1.13-2.09)
[55–65]*2010 … 1.40** (1.03-1.91)
Social class (ref = associate profession)
Farmer 1.78*** (1.29-2.45) 1.78*** (1.29-2.45)
Craftsman 1.19 (0.91-1.54) 1.18 (0.91-1.54)
Manager 0.89 (0.74-1.08) 0.89 (0.74-1.08)
Office worker 1.19*** (1.05-1.34) 1.18*** (1.05-1.33)
Skilled worker 1.24** (1.01-1.53) 1.24** (1.00-1.52)
Non skilled worker 1.64*** (1.38-1.95) 1.64*** (1.38-1.95)
Inactive 2.31*** (1.85-2.89) 2.29*** (1.84-2.86)
Marital status (ref = living in a couple)
Single 1.82*** (1.61-2.06) 1.82*** (1.60-2.05)
Complementary health insurance (ref = private)
Free 1.54*** (1.33-1.78) 1.54*** (1.33-1.78)
No 2.05*** (1.68-2.51) 2.06*** (1.68-2.52)
Health and health care consumption
Chronic disease (ref = no)
Yes 1.28*** (1.15-1.43) 1.28*** (1.14-1.42)
Self-rated health (ref = very good)
[0–4] : poor 2.04*** (1.62-2.58) 2.04*** (1.61-2.58)
[5,6] : fair 1.52*** (1.31-1.76) 1.53*** (1.32-1.77)
[7,8]: good 1.21*** (1.08-1.34) 1.21*** (1.09-1.35)
Nb of consultations with the GP (ref = more then three)
Less than two 1.20*** (1.09-1.33) 1.21*** (1.10-1.33)
Nb of consultations with a specialist (ref = one or more)
None 3.43*** (3.11-3.79) 3.43*** (3.11-3.79)
Risky behaviours
Tobacco consumption (ref = non smoker)
Ex-smoker 0.84*** (0.74-0.94) 0.83*** (0.74-0.94)
Light smoker 0.81*** (0.70-0.92) 0.80*** (0.70-0.92)
Heavy smoker 1.36*** (1.18-1.56) 1.36*** (1.18-1.56)
Alcohol consumption (ref = safe consumer)
Non drinker 1.44*** (1.30-1.59) 1.45*** (1.30-1.60)
Occasionnaly risky consumer 1.09 (0.95-1.25) 1.09 (0.95-1.25)
High risk consumer 1.42*** (1.09-1.85) 1.43*** (1.10-1.86)
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Table 2 Multivariate logistic regression models of the absence of cervical screening (N = 13,177 women) (Continued)
Survey year (ref = 2006)
2008 1.02 (0.92-1.13) 0.86 (0.68-1.09)
2010 1.15** (1.03-1.27) 0.90 (0.71-1.15)
Note: The results were adjusted for the region of residence. Nonresponse categories were included in the models, but their coefficients were not reported in the
final table. Significance level: *** = 1%; ** = 5%.
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pact: not having received a mammogram increased the
odds ratio associated to not having received a FOBT by
3.85 [3.20-4.63].
Discussion
This study aimed to examine the determinants of and
trends in the failure to receive breast, cervical, and colo-
rectal cancer screenings in France between 2006 and
2010, a period in which various incentive policies were
implemented. We focused on three types of cancer that
were either the focus of recent debate or the subject of
mass screening policies that were implemented following
national and international guidelines. However, the supply
context and incentive policies related to these types of
screening differ. A national programme for breast cancer
screening has been in place since 2004 and highly pub-
licised for many years. Mammography is generally pre-
scribed by a GP or gynaecologist and performed in a
radiology centre. A Pap smear is most often performed by
a gynaecologist or GP before it is sent to a laboratory for
analysis, but a national programme has not been estab-
lished (only experiments are ongoing). This test has been
the focus of a number of economic evaluations aiming to
provide recommendations for the vaccine against human
papillomavirus. A national programme for colorectal can-
cer screening that targets the entire population over the
age of 50 years was recently implemented. Colorectal
cancer screening is most often prescribed by a GP but
may also be recommended by a gastroenterologist or
anatomopathologist.
Our results show that the rates of cervical and breast
cancer screening use in France decreased between 2006
and 2010. These results, which are consistent with those
of other studies obtained in different contexts and coun-
tries [21], are particularly disappointing given the main-
tenance or reinforcement of certain incentive policies
(Cancer Plan 2009–2013). In contrast, the rate of colo-
rectal cancer screening uptake increased substantially bet-
ween 2006 and 2010. This result can be explained by the
introduction of a national cancer screening programme in
2009 that combined two actions: a voucher mailed to
eligible individuals on the demand side and a lump sum
payment to GPs on the supply side.
According to our results, young age, low socioeconomic
status, and poor or fair self-rated health had the strongestnegative impact on cervical screening uptake relative to
breast and colorectal cancer screening uptake. This result
could be explained by the absence of a national pro-
gramme for cervical screening and, as a consequence,
reduced media attention on cervical screening and/or
by the costs associated with cervical screening (i.e., the
screening is not free) [22]. Furthermore, the context of
cervical screening differs from that of other types of
cancer screening, as cervical screening is often provided
directly by a gynaecologist during a consultation, which
increases inequalities related to access to care. Women
who lived in a couple were more likely to consult a gynae-
cologist for contraceptive treatment and thus were more
likely to be screened. In addition, the higher screening up-
take for women aged between 25 and 34 years was likely
related to consultation for one or several pregnancies,
which are associated with more frequent visits to spe-
cialists. By extension, the provision of cervical screening
may be related to the proximity of a gynaecologist (i.e.,
living in a more urban area where the density of specialists
is much higher). Indeed, having consulted a gynaecologist
in the past 12 months constituted a very strong deter-
minant of Pap smear and mammography uptake. We
performed separate analyses including gynaecologist visits
adjusted for all other covariates and found that this
variable had a substantial impact on cervical screening
uptake (OR = 7.8 [6.2-9.4]) and a less pronounced impact
on mammography screening (OR = 3.5 [2.5-4.7]). These
results confirm the need to strengthen efforts to reduce
inequalities in access to specialists, especially for cancers
that are not the subject of a national programme (e.g.,
cervical cancer).
Concerning breast cancer screening, socioeconomic
characteristics had affected the likelihood of undergoing
a mammogram, but the effect was less pronounced than
that for cervical screening. A possible explanation for
this result is that the combination of highly publicised
information campaigns for breast cancer in France and
the national screening programme indeed targeted a
larger population, but economic inequalities have per-
sisted: not having private complementary health insu-
rance (whether free or not) decreased the probability of
screening. In France, not having complementary health
insurance and, to a greater extent, receiving free comple-
mentary health insurance are often associated with low
to very low household income. Moreover, even though
Table 3 Multivariate logistic regression model of the
absence of breast cancer screening (N = 6,229 women)
Independant variables No breast cancer screening
Main effects model
OR (95 CI)
Socioeconomic
characteristics
Age (ref = 50–54)
[55–59] 0.75*** (0.62-0.89)
[60–64] 0.78*** (0.64-0.94)
[65–74] 1.06 (0.89-1.27)
Social class (ref = associate profession)
Farmer 1.08 (0.76-1.55)
Craftsman 1.09 (0.78-1.51)
Manager 1.00 (0.76-1.33)
Office worker 1.18 (0.98-1.42)
Skilled worker 1.28 (0.96-1.70)
Non skilled worker 1.62*** (1.26-2.09)
Inactive 1.61*** (1.14-2.28)
Marital status (ref = living in a couple)
Single 1.45*** (1.17-1.80)
Complementary health insurance (ref = private)
Free 1.79*** (1.36-2.37)
No 2.08*** (1.57-2.75)
Health and health care
consumption
Chronic disease (ref = no)
Yes 1.29*** (1.11-1.50)
Self-rated health (ref = very good)
[0–4] : poor 1.87*** (1.38-2.54)
[5,6] : fair 1.20 (0.96-1.49)
[7,8]: good 1.06 (0.88-1.28)
Nb of consultations with the GP (ref = more then three)
Less than two 1.40*** (1.21-1.62)
Nb of consultations with a specialist (ref = one or more)
None 3.00*** (2.59-3.47)
Risky behaviours
Tobacco consumption (ref = non smoker)
Ex-smoker 0.92 (0.77-1.10)
Light smoker 1.08 (0.85-1.36)
Heavy smoker 1.84*** (1.44-2.37)
Alcohol consumption (ref = safe consumer)
Non drinker 1.27*** (1.09-1.48)
Occasionnaly risky consumer 1.14 (0.90-1.44)
High risk consumer 1.26 (0.88-1.80)
Table 3 Multivariate logistic regression model of the
absence of breast cancer screening (N = 6,229 women)
(Continued)
Survey year (ref = 2006)
2008 1.16 (1.00-1.35)
2010 1.25*** (1.07-1.46)
Note: The results were adjusted for the region of residence. Nonresponse
categories were included in the models, but their coefficients were not
reported in the final table. Significance level: *** = 1%; ** = 5%.
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http://www.biomedcentral.com/1472-6963/14/465mammograms are free of charge in the context of orga-
nised cancer screening, lower overall access to the health
system (e.g., physician care) may prevent individuals
from receiving the test. Thus, even though a national
programme was implemented in 2004, i.e., before the
study period, inequalities in access to breast cancer
screening persist and do not seem to have declined over
time.
Regarding colorectal cancer screening, despite the intro-
duction of a national programme in 2009, age-related
screening disparities have persisted: individuals under
54 years of age were less likely to have been tested. The
complementary health insurance variable had no effect on
colorectal cancer screening uptake, in contrast to cervical
and breast cancer screening uptake, over the study period.
However, among males, inequalities related to having free
complementary health insurance (the CMU-C) were
significant in 2010. Moreover, individuals with less access
to health care (GPs or specialists) were less likely to be
tested. Thus, health authorities could intensify efforts
to promote increased access to screening for the most
disadvantaged populations. For this purpose, a national
programme is one mechanism among many and should
likely be complemented by targeted primary prevention
policies aimed at reducing these inequalities.
Another interesting result of our paper concerns the im-
pact of individual risk behaviours and the use or nonuse
of other screening tests. The results for individuals who
engaged in high-risk behaviours in terms of alcohol and
tobacco consumption were consistent with our expec-
tations and the results of previous studies [23,24]. One
possible rationale for their lower screening uptake could
relate to economic trade-offs based on time preferences
[25] and/or fear of disease. However, surprisingly, indivi-
duals reporting very healthy behaviours (never consuming
alcohol, never smoking) also had lower levels of screening
uptake. This result is interesting, as it suggests that more
targeted primary prevention policies are needed for these
individuals, for instance, by combating the notion that
cancer only affects individuals with more risky lifestyles.
Limitations of the study
The main shortcomings of the study are related to the
declarative nature of the data. Specifically, so-called
Table 4 Multivariate logistic regression models of the absence of colorectal cancer screening (N = 5,927 males and
N = 6,229 women)
Independant variables No colorectal cancer screening
main effects model
No colorectal cancer screening
interactions model
No colorectal cancer screening
main effects model
Males Males Females
Socioeconomic characteristics
Age (ref = 50–54)
[55–59] 0.64*** (0.54-0.77) 0.64*** (0.53-0.77) 0.55*** (0.46-0.66)
[60–64] 0.57*** (0.48-0.69) 0.57*** (0.48-0.69) 0.48*** (0.40-0.58)
[65–74] 0.54*** (0.45-0.65) 0.54*** (0.45-0.64) 0.47*** (0.39-0.56)
Social class (ref = associate profession)
Farmer 1.46** (1.08-1.99) 1.46*** (1.07-1.99) 1.06 (0.76-1.50)
Craftsman 1.19 (0.95-1.50) 1.20 (0.95-1.51) 1.22 (0.88-1.68)
Manager 0.99 (0.82-1.19) 0.99 (0.82-1.19) 0.96 (0.75-1.22)
Office worker 1.15 (0.88-1.51) 1.15 (0.88-1.51) 0.87 (0.74-1.03)
Skilled worker 1.08 (0.90-1.29) 1.08 (0.90-1.28) 1.10 (0.83-1.47)
Non skilled worker 1.60*** (1.23-2.08) 1.62*** (1.25-2.11) 1.03 (0.80-1.33)
Inactive 7.18 (0.92-55.82) 6.07 (0.77-47.70) 1.08 (0.75-1.57)
Marital status (ref = living in a couple)
Single 1.12 (0.77-1.62) 1.13 (0.77-1.64) 1.14 (0.90-1.44)
Complementary health insurance (ref = private)
Free 1.18 (0.81-1.72) 0.53** (0.30-0.94) 1.05 (0.76-1.45)
No 1.40 (1.00-1.97) 1.10 (0.64-1.90) 1.20 (0.85-1.70)
Compl. health insurance*survey year (ref: compl health insurance = 'private'; survey year = '2008')
Free* 2010 … 4.31*** (1.90-9.76) …
Health and health care consumption
Chronic disease (ref = no)
Yes 0.95 (0.82-1.10) 0.96 (0.83-1.11) 0.97 (0.84-1.12)
Self-rated health (ref = very good)
[0–4]: poor 1.31 (0.94-1.82) 1.32 (0.95-1.83) 1.48** (1.07-2.03)
[5,6]: fair 1.21 (0.97-1.50) 1.20 (0.97-1.49) 1.17 (0.95-1.45)
[7,8]: good 1.02 (0.86-1.21) 1.03 (0.86-1.22) 1.14 (0.96-1.36)
Nb of consultations with a GP (ref = more then three)
Less then two 1.22*** (1.06-1.41) 1.22*** (1.06-1.41) 1.18** (1.02-1.36)
Nb of consultations with a specialist (ref = one or more)
None 1.29*** (1.12-1.49) 1.30*** (1.12-1.50) 1.68*** (1.45-1.96)
Risky behaviours
Tobacco consumption (ref = non smoker)
Ex-smoker 1.08 (0.93-1.27) 1.08 (0.93-1.27) 1.00 (0.85-1.17)
Light smoker 1.28** (1.03-1.59) 1.29*** (1.04-1.62) 1.20 (0.94-1.52)
Heavy smoker 1.70*** (1.31-2.22) 1.71*** (1.31-2.23) 1.68*** (1.23-2.28)
Alcohol consumption (ref = safe consumer)
Non drinker 1.19 (0.96-1.48) 1.18 (0.95-1.47) 1.22** (1.05-1.42)
Occasionnaly risky consumer 0.95 (0.82-1.11) 0.95 (0.82-1.11) 1.19 (0.95-1.49)
High risk consumer 1.13 (0.93-1.37) 1.13 (0.93-1.38) 1.44 (0.98-2.09)
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Table 4 Multivariate logistic regression models of the absence of colorectal cancer screening (N = 5,927 males and
N = 6,229 women) (Continued)
Survey year (ref = 2008)
2006 1.15 (0.99-1.35) 1.12 (0.95-1.23) 1.52*** (1.30-1.77)
2010 0.45*** (0.39-0.52) 0.42*** (0.36-0.49) 0.45*** (0.39-0.52)
Note: The results were adjusted for the region of residence. Nonresponse categories were included in the models, but their coefficients were not reported in the
final table. Significance level: *** = 1%; ** = 5%.
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http://www.biomedcentral.com/1472-6963/14/465social desirability bias may have resulted in an over-
estimation of screening uptake. In France, the Institute
for Public Health Surveillance (INVS) provides an an-
nual estimation of breast cancer screening (since 2004)
and colorectal cancer screening (since 2009). Concerning
breast cancer, 49.3% of individuals were screened in
2006, 52.5% in 2008 and 52.0% in 2010e, and concerning
colorectal cancer, 34% of individuals were screened bet-
ween 2009 and 2010f. Thus, the screening rates in the
ESPS samples seem to overestimate INVS’s rates (even
though they are not comparable for breast cancer scree-
ning because the “inclusion” period is not the same), but
they are consistent with other self-reported measures
provided for instance by the French National Institute for
Prevention and Health Education (INPES) [13].
Other determinants of screening, such as cancer-related
family history [26], beliefs and knowledge [27-30], or the
availability of doctors [31,32], remained unidentifiable in
our study. Other studies have also shown the impact of in-
come on the probability of being screened [18,33]. Owing
to numerous missing values and to avoid increasing the
risk of multicollinearity with the health insurance and
social class variables, we did not adjust for income.
Conclusion
Our results demonstrate that persistent obstacles to
screening, which are primarily related to socioeconomic
characteristics, health care access, and risky behaviours,
remain. However, we could not precisely determine if
low screening uptake result from lower patient uptake
(i.e., patient choice) or from less access to screening ser-
vices (i.e., system-level barriers). Further studies should
more specifically investigate the associations among
attitudes/beliefs, individual barriers in access to care,
and screening uptake.
Greater coordination between the different actors in-
volved in cancer screening also seems necessary because,
in the context of French national programmes—particu-
larly the breast cancer screening programme—the GP or
gynaecologist is not always aware of whether their pa-
tients have received a mammogram. Some studies argue
that the GP’s role should be to coordinate the patient’s
various screenings [34,35]. Indeed, GPs are the most
relevant actors in the prescription of colorectal cancer
screening [36], and they play an important (advisory)
role in breast cancer and cervical screenings [37].Endnotes
aFor a complete description of the authorisation:
http://legimobile.fr/fr/cnil/del/aut/2010/2010-003/.
bIn France, private complementary health insurance is
generally purchased to cover reinsurable copayments
that are not covered by public health insurance: for any
given service, the reimbursement is computed as a
percentage of regulated prices, and some providers are
also allowed to charge additional fees. Below a certain
income threshold, individuals can benefit from a form of
free complementary health insurance called the CMU-C.
Individuals benefiting from the CMU-C are generally
more socially and economically disadvantaged.
cWe did not include breast cancer and colorectal can-
cer screening as predictors of cervical cancer screening
uptake because the age groups differed.
dWe thank an anonymous referee for offering two other
rationales for this stratification: first other factors affecting
colorectal screening may differ by sex (e.g. health con-
sumption, risky behaviours); second, this stratification is
useful for examining whether breast cancer screening
compliance predicts the likelihood of colorectal screening
among women.
ehttp://www.invs.sante.fr/Dossiers-thematiques/Maladies-
chroniques-et-traumatismes/Cancers/Evaluation-des-
programmes-de-depistage-des-cancers/Evaluation-du-
programme-de-depistage-du-cancer-du-sein.
fhttp://www.invs.sante.fr/Dossiers-thematiques/Maladies-
chroniques-et-traumatismes/Cancers/Evaluation-des-
programmes-de-depistage-des-cancers/Evaluation-du-
programme-de-depistage-du-cancer-colorectal.
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